Iq Eq Fund Management (Ireland) LTD Zynerba Pharmaceuticals, Inc. Transaction History

Iq Eq Fund Management (Ireland) LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.5 - $0.72 $3,056 - $4,400	6,112 Added 5.23%	122,892 $65,000
Q3 2022 Oct 26, 2022	SELL	$0.87 - $1.36 $93,473 - $146,119	-107,441 Reduced 47.92%	116,780 $85,000
Q2 2022 Aug 03, 2022	BUY	$0.86 - $2.06 $9,246 - $22,149	10,752 Added 5.04%	224,221 $256,000
Q1 2022 Apr 28, 2022	BUY	$1.83 - $3.02 $18,226 - $30,079	9,960 Added 4.89%	213,469 $438,000
Q4 2021 Feb 02, 2022	BUY	$2.88 - $4.3 $53,493 - $79,868	18,574 Added 10.04%	203,509 $586,000
Q3 2021 Oct 27, 2021	SELL	$3.72 - $5.35 $2.89 Million - $4.16 Million	-777,697 Reduced 80.79%	184,935 $784,000
Q2 2021 Jul 19, 2021	BUY	$3.83 - $5.98 $923,202 - $1.44 Million	241,045 Added 33.4%	962,632 $5.09 Million
Q1 2021 May 11, 2021	BUY	$3.33 - $8.76 $2.16 Million - $5.69 Million	649,418 Added 899.86%	721,587 $3.36 Million
Q4 2020 Jan 29, 2021	BUY	$3.27 - $4.64 $132,817 - $188,462	40,617 Added 128.73%	72,169 $238,000
Q3 2020 Oct 22, 2020	BUY	$3.23 - $4.3 $62,229 - $82,843	19,266 Added 156.81%	31,552 $104,000
Q2 2020 Jul 22, 2020	BUY	$3.31 - $6.54 $40,666 - $80,350	12,286 New	12,286 $41,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.